PABS Negotiations: Linking Pathogen Sharing to Fair Access

Why in News?

At the UN pandemic meeting on 25 September, reported by PIB on 26 September, India sought fair Pathogen Access and Benefit Sharing (PABS) and cautioned against prejudging ongoing annex negotiations.

• India linked access to pathogens and biological resources with timely vaccines, diagnostics, therapeutics, technologies and other benefits for contributing countries.
• The WHO Pandemic Agreement was adopted in May 2025; India described a fair PABS system as essential to its credibility.
• India said the political declaration should not prejudge the PABS annex and should reflect national circumstances and capacities.
• The statement called for national sovereignty alongside global solidarity; it did not announce a completed annex or an operational allocation mechanism.

• Early warning depends on cooperation, but countries need confidence that sharing biological resources will not leave their populations behind when products become available.
• Equity concerns both the terms of cooperation and access during emergencies; a diplomatic commitment alone does not establish delivery or affordability.

UPSC Relevance

Prelims Relevance

• PABS: Pathogen Access and Benefit Sharing.
• World Health Assembly: body that adopted the WHO Pandemic Agreement.
• PABS annex: separate negotiating work on the system’s rules.
• Diagnostics, vaccines and therapeutics: detection, prevention and treatment functions.
• Adoption and ratification: distinct stages in the treaty process.

Mains Relevance

GS Paper 2

• Equity, national sovereignty and accountability in global health governance.
• Linking contributions to international cooperation with timely access to essential health products.

GS Paper 3

• The relationship between pathogen research and development of medical countermeasures.

Essay

• Trust in international cooperation depends on whether shared contributions produce shared benefits.

Background and Context

What access and benefit sharing connect

PABS addresses a practical question: how can countries help identify a pandemic threat without losing fair access to the tools developed against it?

• Pathogen access concerns material and information needed to understand disease threats. Researchers can use these inputs to investigate the organism, assess risks and work on medical countermeasures before an emergency expands.
• Benefit sharing concerns what follows from cooperation. India named vaccines, diagnostics, therapeutics, technologies and other benefits, making clear that providing an input and receiving a useful health product are different steps.
• Vaccines, diagnostics and therapeutics serve different purposes: prevention, detection and treatment. Fair access cannot be judged solely by vaccine availability when countries also need tests and treatments to manage an outbreak.
• The central relationship is reciprocity, rather than an automatic one-for-one exchange of samples for doses. The unfinished annex must translate shared principles into workable arrangements; this statement does not establish their final terms.
• Timeliness matters because access after an emergency peaks may offer less protection. India’s position asks whether contributing countries can obtain useful products when needed, rather than merely receiving an eventual promise of support.

Why sovereignty and cooperation must work together

The negotiating challenge is to make sharing dependable while ensuring that countries retain a meaningful role in decisions affecting their resources and populations.

• National sovereignty means countries’ authority over biological resources remains relevant to cooperation. The official position combines respect for that authority with timely benefits; it does not present pathogen sharing as unrestricted access without conditions.
• Shared early warning and domestic responsibility are complementary. Detecting a threat in one country can inform preparedness elsewhere, but international arrangements still need national institutions capable of carrying out agreed responsibilities effectively.
• Trust is a practical design issue: contributors need confidence that cooperation will support their populations. This explains why access and benefits are discussed together, even though the final operational commitments remain under negotiation.
• Technology access broadens the equity discussion beyond receiving finished products. India included technologies among the benefits sought, but its statement does not establish compulsory technology transfers or specify an agreed mechanism for providing them.
• Member-state consultation also matters when reviewing pandemic tools, assessments and data. India highlighted their policy implications, showing that technical cooperation involves governance choices about participation and national capacity, alongside the science of disease control.

Political commitment is not completed implementation

Keep three stages separate: political endorsement, adoption of an agreement, and the legal and practical steps that make its arrangements work.

• A political declaration records a collective political position. India’s warning against prejudging the annex means that broad endorsement should not be treated as settling detailed questions still being negotiated through the PABS process.
• Agreement adoption is an institutional milestone, not evidence that every country is already bound. WHO’s adoption announcement distinguishes the agreement from subsequent signature and ratification processes following adoption of the PABS annex.
• The annex carries operational importance because general commitments need agreed rules. The September statement explicitly describes negotiations as ongoing, so neither a completed system nor compulsory sharing duties should be inferred from this meeting.
• Implementation capacity is a further test: access promises must become usable products and services. India stressed national circumstances and capacities, rather than suggesting that adopting international language automatically creates equivalent capabilities in every country.
• For analysis, distinguish a proposed safeguard from an achieved result. Fair allocation, dependable delivery and credible accountability are questions for judging the eventual system, not outcomes demonstrated by the latest diplomatic statement itself.

Way Forward

Make the eventual rules testable

• Define responsibilities and timelines clearly so participating countries understand what sharing entails and when benefits should become available.
• Build transparent reporting and review into the agreed arrangements so product-access commitments can be assessed against delivery during an emergency.
• Align national implementation with agreed international obligations and domestic capacity, while keeping unfinished negotiating provisions distinct from operative rules.

Conclusion

• PABS puts a distributional question inside pandemic cooperation: countries that contribute biological resources need credible, timely benefits. India’s intervention supports that linkage while preserving sovereignty and the integrity of unfinished negotiations.
• The durable distinction is between commitment and implementation. Assess an eventual PABS system by its agreed obligations and delivered access, while avoiding claims that this meeting completed the annex or guaranteed products to every country.

UPSC Practice Questions

Prelims MCQ 1

With reference to Pathogen Access and Benefit Sharing (PABS), consider the following statements:

1. India’s stated benefit-sharing concerns include diagnostics and therapeutics as well as vaccines.
2. Adoption of the WHO Pandemic Agreement proves that the PABS annex negotiations are complete.
3. India has linked fair benefit sharing with respect for national sovereignty.

How many of the above statements are correct?

(a) Only one (b) Only two (c) All three (d) None

Answer: (b) Only two

Explanation:

Statements 1 and 3 reflect India’s position. Statement 2 is incorrect: the September 2026 statement explicitly refers to ongoing negotiations on the PABS annex.

Prelims MCQ 2

Which distinction best explains India’s caution concerning the political declaration and PABS annex?

(a) A political declaration automatically ratifies every associated treaty. (b) Pathogen research eliminates the need for diagnostic products. (c) Political endorsement should not be treated as settling provisions still under negotiation. (d) Benefit sharing concerns vaccines exclusively.

Answer: (c) Political endorsement should not be treated as settling provisions still under negotiation.

Explanation:

India said the declaration should not prejudge the annex negotiations. Broad political support and agreement on detailed operational provisions are different matters.

UPSC Mains Questions

1. How can linking pathogen access with benefit sharing strengthen international pandemic cooperation? Discuss the associated concerns of equity and national sovereignty.
2. Distinguish political commitment from operational implementation in global health agreements, with reference to ongoing PABS annex negotiations.

Sources: PIB, Ministry of Health and Family Welfare and World Health Organization.

Frequently Asked Questions